Free Trial

Lexeo Therapeutics (LXEO) Institutional Ownership

→ How this is some devastating news (From WealthPress) (Ad)
Free LXEO Stock Alerts
$13.85
-0.17 (-1.21%)
(As of 05/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$98.52M
Number of
Institutional Sellers
(last 12 months)
0
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Lexeo Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 RA Capital Management L.P.660,938$10.36M0.1%N/A2.006%
5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434%
5/16/2024 Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713%
5/14/2024 American International Group Inc.5,053$79K0.0%N/A0.015%
5/10/2024 Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462%
5/1/2024 BNP Paribas Financial Markets4,781$75K0.0%N/A0.015%
4/29/2024 Cornell University126,258$1.98M30.0%N/A0.383%
2/20/2024 Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268%
2/15/2024 Omega Fund Management LLC2,157,623$28.96M23.5%N/A8.096%
2/15/2024 Blackstone Inc.696,110$9.34M0.0%N/A2.612%
(Data available from 1/1/2016 forward)

LXEO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LXEO shares?

During the previous two years, 10 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Eventide Asset Management LLC ($40.30M), Janus Henderson Group PLC ($39.80M), Omega Fund Management LLC ($28.96M), Artal Group S.A. ($12.57M), RA Capital Management L.P. ($10.36M), Blackstone Inc. ($9.34M), and Vanguard Group Inc. ($7.55M).Learn more on LXEO's institutional investors.

What percentage of Lexeo Therapeutics stock is owned by institutional investors?

60.67% of Lexeo Therapeutics stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Which institutional investors have been buying Lexeo Therapeutics stock?

Of the 10 institutional investors that purchased Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Blackstone Inc. ($696.11K), RA Capital Management L.P. ($660.94K), Janus Henderson Group PLC ($210.05K), Artal Group S.A. ($198.28K), and Cornell University ($126.26K).

How much institutional buying is happening at Lexeo Therapeutics?

Institutional investors have bought a total of 7,127,495 shares in the last 24 months. This purchase volume represents approximately $98.52M in transactions.


Related Companies:
This page (NASDAQ:LXEO) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Shocking $16T Elon Musk Crypto Leak
Crypto 101 Media
Urgent Nvidia Warning
Altimetry
Dems have chosen Biden replacement?
Paradigm Press
Most important medical advance in 100 years
The Oxford Club
Next President (Not Trump. Not Biden.)
The Freeport Society
Crypto Pioneer Says: “The last crypto bull market has begun.”
InvestorPlace
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders